# Alterity Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2020

- Company: [Alterity Therapeutics Ltd](/companies/athe.md) (CIK 1131343)
- Form: 20-F
- Filed: 2020-09-15
- Accepted by EDGAR: Sep 15, 2020, 06:19 ET
- Period: 2020-06-30
- Accession: 0001213900-20-026557
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131343/000121390020026557/f20f2020_alteritytherape.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131343/000121390020026557/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Interest expense | 12 months, 2019-07-01 to 2020-06-30 | AUD 3.9k | us-gaap:InterestExpense |
| Operating cash flow | 12 months, 2019-07-01 to 2020-06-30 | −AUD 9.4m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2019-07-01 to 2020-06-30 | AUD 16.7k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2020-06-30 | AUD 9.2m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2020-06-30 | AUD 9.8m | ifrs-full:CurrentAssets |
| Total assets | at 2020-06-30 | AUD 9.9m | ifrs-full:Assets |
| Current liabilities | at 2020-06-30 | AUD 2.7m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2020-06-30 | AUD 2.8m | ifrs-full:Liabilities |
| Shareholders' equity | at 2020-06-30 | AUD 7.2m | ifrs-full:Equity |
| Shares outstanding | at 2020-06-30 | 1,037,358,032 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131343/000121390020026557/f20f2020_alteritytherape.htm

Filed Sep 15, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-026557. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.